Abstract:Background
Conclusions: Our study has significant scope on targeting antibacterial metabolites. The described method could also be used as a rapid and costeffective tool for screening other bioactivity products. As such, this article could offer a fast approach to isolate drug-lead compounds from microorganisms.IntroductIon A spergillus genus is well known for its medical and commercial importance (1). They are prolific producers of lifesaving drugs, devastating toxins, or mass produced industrial enzymes (2). Many clinically beneficial secondary metabolites are produced by Aspergillus genus, such as lovastatin, terrein, griseofulvin. Lovastatin, also known as mevinolin or monacolin K, is effective clinical drug used for reducing serum cholesterol and slowing the progression of atherosclerosis. Lovastatin and its related compounds inhibit cholesterol synthesis by inhibiting the rate-limiting step in cellular cholesterol biosynthesis (3). Terrein, one of Aspergillus major secondary metabolites has ecological, antimicrobial, antiproliferative and antioxidative activities (4). Some strains of Aspergillus can biosynthesize gluconic acid which is a bulk